Cargando…
Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021
BACKGROUND: There are limited antimicrobial resistance (AMR) surveillance data from low- and middle-income countries, especially from the Pacific Islands region. AMR surveillance data is essential to inform strategies for AMR pathogen control. METHODS: We performed a retrospective analysis of antimi...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926303/ https://www.ncbi.nlm.nih.gov/pubmed/36798514 http://dx.doi.org/10.1016/j.lanwpc.2022.100677 |
_version_ | 1784888251377516544 |
---|---|
author | Loftus, Michael J. Everts, Richard J. Cheng, Allen C. Eti, Perenise Fakasiieiki, Timote Isaia, Lupeoletalelei Isopo, Enita Jenney, Adam W.J. Lameko, Viali Leaupepe, Hinauri Leavai, Folototo Lee, Sue J. Moungaevalu, Mele Stewardson, Andrew J. Tekoaua, Rosemary Tou, Douglas Wuatai, Geoffrey Peleg, Anton Y. |
author_facet | Loftus, Michael J. Everts, Richard J. Cheng, Allen C. Eti, Perenise Fakasiieiki, Timote Isaia, Lupeoletalelei Isopo, Enita Jenney, Adam W.J. Lameko, Viali Leaupepe, Hinauri Leavai, Folototo Lee, Sue J. Moungaevalu, Mele Stewardson, Andrew J. Tekoaua, Rosemary Tou, Douglas Wuatai, Geoffrey Peleg, Anton Y. |
author_sort | Loftus, Michael J. |
collection | PubMed |
description | BACKGROUND: There are limited antimicrobial resistance (AMR) surveillance data from low- and middle-income countries, especially from the Pacific Islands region. AMR surveillance data is essential to inform strategies for AMR pathogen control. METHODS: We performed a retrospective analysis of antimicrobial susceptibility results from the national microbiology laboratories of four Pacific Island countries – the Cook Islands, Kiribati, Samoa and Tonga – between 2017 and 2021. We focused on four bacteria that have been identified as ‘Priority Pathogens’ by the World Health Organization: Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa. FINDINGS: Following deduplication, a total of 20,902 bacterial isolates was included in the analysis. The most common organism was E. coli (n = 8455) followed by S. aureus (n = 7830), K. pneumoniae (n = 2689) and P. aeruginosa (n = 1928). The prevalence of methicillin resistance among S. aureus isolates varied between countries, ranging from 8% to 26% in the Cook Islands and Kiribati, to 43% in both Samoa and Tonga. Ceftriaxone susceptibility remained high to moderate among E. coli (87%–94%) and K. pneumoniae (72%–90%), whereas amoxicillin + clavulanate susceptibility was low against these two organisms (50%–54% and 43%–61%, respectively). High susceptibility was observed for all anti-pseudomonal agents (83%–99%). INTERPRETATION: Despite challenges, these Pacific Island laboratories were able to conduct AMR surveillance. These data provide valuable contemporary estimates of AMR prevalence, which will inform local antibiotic formularies, treatment guidelines, and national priorities for AMR policy. FUNDING: Supported by the 10.13039/501100000925National Health and Medical Research Council. |
format | Online Article Text |
id | pubmed-9926303 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-99263032023-02-15 Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021 Loftus, Michael J. Everts, Richard J. Cheng, Allen C. Eti, Perenise Fakasiieiki, Timote Isaia, Lupeoletalelei Isopo, Enita Jenney, Adam W.J. Lameko, Viali Leaupepe, Hinauri Leavai, Folototo Lee, Sue J. Moungaevalu, Mele Stewardson, Andrew J. Tekoaua, Rosemary Tou, Douglas Wuatai, Geoffrey Peleg, Anton Y. Lancet Reg Health West Pac Articles BACKGROUND: There are limited antimicrobial resistance (AMR) surveillance data from low- and middle-income countries, especially from the Pacific Islands region. AMR surveillance data is essential to inform strategies for AMR pathogen control. METHODS: We performed a retrospective analysis of antimicrobial susceptibility results from the national microbiology laboratories of four Pacific Island countries – the Cook Islands, Kiribati, Samoa and Tonga – between 2017 and 2021. We focused on four bacteria that have been identified as ‘Priority Pathogens’ by the World Health Organization: Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa. FINDINGS: Following deduplication, a total of 20,902 bacterial isolates was included in the analysis. The most common organism was E. coli (n = 8455) followed by S. aureus (n = 7830), K. pneumoniae (n = 2689) and P. aeruginosa (n = 1928). The prevalence of methicillin resistance among S. aureus isolates varied between countries, ranging from 8% to 26% in the Cook Islands and Kiribati, to 43% in both Samoa and Tonga. Ceftriaxone susceptibility remained high to moderate among E. coli (87%–94%) and K. pneumoniae (72%–90%), whereas amoxicillin + clavulanate susceptibility was low against these two organisms (50%–54% and 43%–61%, respectively). High susceptibility was observed for all anti-pseudomonal agents (83%–99%). INTERPRETATION: Despite challenges, these Pacific Island laboratories were able to conduct AMR surveillance. These data provide valuable contemporary estimates of AMR prevalence, which will inform local antibiotic formularies, treatment guidelines, and national priorities for AMR policy. FUNDING: Supported by the 10.13039/501100000925National Health and Medical Research Council. Elsevier 2023-02-02 /pmc/articles/PMC9926303/ /pubmed/36798514 http://dx.doi.org/10.1016/j.lanwpc.2022.100677 Text en © 2022 Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Articles Loftus, Michael J. Everts, Richard J. Cheng, Allen C. Eti, Perenise Fakasiieiki, Timote Isaia, Lupeoletalelei Isopo, Enita Jenney, Adam W.J. Lameko, Viali Leaupepe, Hinauri Leavai, Folototo Lee, Sue J. Moungaevalu, Mele Stewardson, Andrew J. Tekoaua, Rosemary Tou, Douglas Wuatai, Geoffrey Peleg, Anton Y. Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021 |
title | Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021 |
title_full | Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021 |
title_fullStr | Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021 |
title_full_unstemmed | Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021 |
title_short | Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021 |
title_sort | antimicrobial susceptibility of bacterial isolates from clinical specimens in four pacific island countries, 2017–2021 |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926303/ https://www.ncbi.nlm.nih.gov/pubmed/36798514 http://dx.doi.org/10.1016/j.lanwpc.2022.100677 |
work_keys_str_mv | AT loftusmichaelj antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 AT evertsrichardj antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 AT chengallenc antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 AT etiperenise antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 AT fakasiieikitimote antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 AT isaialupeoletalelei antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 AT isopoenita antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 AT jenneyadamwj antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 AT lamekoviali antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 AT leaupepehinauri antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 AT leavaifolototo antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 AT leesuej antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 AT moungaevalumele antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 AT stewardsonandrewj antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 AT tekoauarosemary antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 AT toudouglas antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 AT wuataigeoffrey antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 AT pelegantony antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021 |